We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$1.32M
Cap. Flow
-$7.19M
Cap. Flow %
-6.06%
Top 10 Hldgs %
45.57%
Holding
71
New
6
Increased
16
Reduced
17
Closed
9
Avg Time Held
9.5 quarters
Top 10 Avg Time Held
9.9 quarters
Top 20 Avg Time Held
8.3 quarters

Top Buys

Rank Stock Value
1
ARE icon
Alexandria Real Estate Equities
ARE
+$1.77M
2
SRCE icon
1st Source
SRCE
+$1.08M
3
RPRX icon
Royalty Pharma
RPRX
+$953K
4
LYB icon
LyondellBasell Industries
LYB
+$906K
5
CMCO icon
Columbus McKinnon
CMCO
+$882K

Top Sells

Rank Stock Value
1
ARKO icon
ARKO Corp
ARKO
+$1.35M
2
WGO icon
Winnebago Industries
WGO
+$1.34M
3
ALK icon
Alaska Air
ALK
+$1.24M
4
ICLR icon
Icon
ICLR
+$1.23M
5
PFE icon
Pfizer
PFE
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 35.54%
2 Materials 13.9%
3 Consumer Staples 10.23%
4 Industrials 8.88%
5 Financials 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CGNT icon
26
Cognyte Software
CGNT
$631M
$1.5M 1.27%
160,000
– –
2025 Q2
2 quarters
CRGY icon
27
Crescent Energy
CRGY
$4.24B
$1.47M 1.24%
175,000
– –
2025 Q3
1 quarter
ARE icon
28
Alexandria Real Estate Equities
ARE
$7.15B
$1.47M 1.24%
+30,000
New +$1.77M
2025 Q4
0 quarters
VTOL icon
29
Bristow Group
VTOL
$1.19B
$1.46M 1.23%
40,000
+10,000
+33% +$376K
2025 Q2
2 quarters
OGN icon
30
Organon & Co
OGN
$3.62B
$1.43M 1.21%
200,000
-25,000
-11% -$198K
2023 Q2
10 quarters
THFF icon
31
First Financial Corp
THFF
$870M
$1.36M 1.15%
22,500
– –
2024 Q1
7 quarters
LYB icon
32
LyondellBasell Industries
LYB
$19.7B
$1.3M 1.1%
30,000
+20,000
+200% +$906K
2025 Q3
1 quarter
BBT icon
33
Beacon Financial Corp
BBT
$2.27B
$1.27M 1.07%
48,300
-27,300
-36% -$691K
2025 Q3
1 quarter
AVIR icon
34
Atea Pharmaceuticals
AVIR
$371M
$1.27M 1.07%
355,000
-145,000
-29% -$461K
2021 Q2
18 quarters
SMG icon
35
ScottsMiracle-Gro
SMG
$2.88B
$1.17M 0.98%
20,000
– –
2025 Q2
2 quarters
CLPT icon
36
ClearPoint Neuro
CLPT
$287M
$1.09M 0.92%
80,000
– –
2021 Q4
16 quarters
SRCE icon
37
1st Source
SRCE
$2.03B
$1.09M 0.92%
+17,500
New +$1.08M
2025 Q4
0 quarters
IOVA icon
38
Iovance Biotherapeutics
IOVA
$6.5B
$1.09M 0.92%
400,000
-300,000
-43% -$694K
2023 Q3
9 quarters
SABR icon
39
Sabre
SABR
$722M
$1.09M 0.92%
800,000
– –
2023 Q1
11 quarters
XOMA icon
40
DELISTED
Xoma
XOMA
$1.06M 0.9%
40,000
-8,000
-17% -$257K
2023 Q4
8 quarters
DIT icon
41
AMCON Distributing
DIT
$60.2M
$997K 0.84%
13,500
– –
2020 Q4
20 quarters
ELDN icon
42
Eledon Pharmaceuticals
ELDN
$184M
$982K 0.83%
650,000
+50,000
+8% +$119K
2021 Q1
19 quarters
HRTX icon
43
Heron Therapeutics
HRTX
$70.2M
$975K 0.82%
750,000
– –
2020 Q4
20 quarters
EEFT icon
44
Euronet Worldwide
EEFT
$2.35B
$951K 0.8%
12,500
-5,000
-29% -$390K
2025 Q2
2 quarters
CMCO icon
45
Columbus McKinnon
CMCO
$440M
$949K 0.8%
+55,000
New +$882K
2025 Q4
0 quarters
CTSO icon
46
Cytosorbents Corp
CTSO
$10.6M
$944K 0.8%
73,825
+9,419
+15% +$145K
2021 Q1
19 quarters
NWL icon
47
Newell Brands
NWL
$2.34B
$744K 0.63%
200,000
+100,000
+100% +$404K
2025 Q1
3 quarters
SVC
48
Service Properties Trust
SVC
$782M
$736K 0.62%
80,000
+20,000
+33% +$201K
2021 Q3
17 quarters
LTRN icon
49
Lantern Pharma
LTRN
$9.75M
$682K 0.57%
225,000
– –
2022 Q1
15 quarters
PROF icon
50
Profound Medical
PROF
$245M
$630K 0.53%
+80,000
New +$514K
2025 Q4
0 quarters
1
2
3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q4 2025 Portfolio in Review

As of Q4 2025, CM Management held 71 positions worth $119M, down 1.1% from $120M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

CM Management withdrew a net $7.19M in Q4 2025, closing 9 positions and reducing 17 holdings. Its most notable exit was Winnebago Industries, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Materials and Consumer Staples.

Against the trend, CM Management opened a new position in Alexandria Real Estate Equities worth $1.47M.

  • CM Management's largest Q4 2025 buy was Alexandria Real Estate Equities: 30,000 shares worth $1.47M.
  • CM Management added most to Royalty Pharma in Q4 2025, an estimated $953K increase.
  • CM Management's biggest Q4 2025 reduction was ARKO Corp, cutting an estimated $1.35M.
  • CM Management fully exited Winnebago Industries in Q4 2025, selling an estimated $1.34M.
  • CM Management's ten largest holdings make up 46% of its $119M portfolio in Q4 2025.
  • CM Management opened 6 new positions and closed 9 in Q4 2025.
  • CM Management's portfolio value fell 1.1% quarter-over-quarter to $119M.

Based on CM Management's 13F filing for Q4 2025, filed 2 Feb 2026.